Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCELERON PHARMA INCXLRN · Entity 15780 | EVP & Chief Medical Officer | January 25, 2019 | January 29, 2019 |
| Immunovant, Inc.IMVT · Entity 3632 | Chief Medical Officer | December 18, 2019 | December 20, 2019 |
| MeiraGTx Holdings plcMGTX · Entity 4734 | CHIEF MEDICAL OFFICER | June 25, 2026 | June 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCELERON PHARMA INC
Report date January 25, 2019 · Filed January 29, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,103 |
Reported balance
After 2019-01-25 transaction · row 1
1 source rowRow 1 · 2019-01-25 · Grant · Acquired 2,200 · Balance 19,103 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $41.64 · Expires 2029-01-25 | Direct | 13,000 |
Reported balance
After 2019-01-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-01-25 · Grant · Acquired 13,000 · Balance 13,000 F1: The shares of common stock underlying this stock option award vest in equal quarterly installments over the four years after January 1, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of common stock underlying this stock option award vest in equal quarterly installments over the four years after January 1, 2019.
Immunovant, Inc.
Report date December 18, 2019 · Filed December 20, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.86 · Expires 2029-07-28 | Direct | 380,325 |
Reported balance
After 2019-12-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-12-18 · Grant · Acquired 380,325 · Balance 380,325 F2: In connection with the share exchange transaction pursuant to which Health Sciences Acquisitions Corporation ("HSAC") acquired 100% of the issued and outstanding shares of Immunovant Sciences Ltd., the option to purchase 777,656 shares of Immunovant Sciences Ltd. at exercise price of $3.84 per share, was assumed by HSAC and converted into an option to purchase shares of the Issuer (formerly known as HSAC). F1: 25% of the shares underlying the option vests on the first anniversary of the grant date, and the remainder vests in 12 equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the shares underlying the option vests on the first anniversary of the grant date, and the remainder vests in 12 equal quarterly installments thereafter.
F2: In connection with the share exchange transaction pursuant to which Health Sciences Acquisitions Corporation ("HSAC") acquired 100% of the issued and outstanding shares of Immunovant Sciences Ltd., the option to purchase 777,656 shares of Immunovant Sciences Ltd. at exercise price of $3.84 per share, was assumed by HSAC and converted into an option to purchase shares of the Issuer (formerly known as HSAC).
MeiraGTx Holdings plc
Report date June 25, 2026 · Filed June 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 100,000 |
Reported balance
After 2026-06-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-25 · Grant · Acquired 100,000 · Balance 100,000 F1: Each restricted share unit converts into one ordinary share upon vesting. F2: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted share unit converts into one ordinary share upon vesting.
F2: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2026 Filed Jun 30, 2026 01:19 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantRestricted Share Units · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001745347-26-000010 · form4-06302026_010612.xml · derivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Ordinary Shares · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F2 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:25 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionRestricted Share Units · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001745347-26-000006 · form4-02242026_020202.xml · derivative · entry 3 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:25 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Tax withholdingOrdinary Shares | 2,952 | $7.45 | $21,992.40 |
DisclosureSEC source: 0001745347-26-000006 · form4-02242026_020202.xml · nonDerivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,888 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 02:25 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionOrdinary Shares | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745347-26-000006 · form4-02242026_020202.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,840 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on February 21, 2023. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 17, 2026 Filed Jan 22, 2026 02:25 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionRestricted Share Units · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001745347-26-000004 · form4-01222026_020138.xml · derivative · entry 3 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Ordinary Shares · 35,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-half of restricted share units granted on January 17, 2024. F1 · derivative.expiration_date: Represents vesting of one-half of restricted share units granted on January 17, 2024. Read SEC document |
| January 17, 2026 Filed Jan 22, 2026 02:25 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Tax withholdingOrdinary Shares | 13,951 | $7.42 | $103,516.42 |
DisclosureSEC source: 0001745347-26-000004 · form4-01222026_020138.xml · nonDerivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,340 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 17, 2026 Filed Jan 22, 2026 02:25 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionOrdinary Shares | 35,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745347-26-000004 · form4-01222026_020138.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-half of restricted share units granted on January 17, 2024. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 02:03 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionRestricted Share Units · Derivative | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001745347-26-000002 · form4-01092026_020105.xml · derivative · entry 3 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 02:03 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Tax withholdingOrdinary Shares | 6,729 | $7.73 | $52,015.17 |
DisclosureSEC source: 0001745347-26-000002 · form4-01092026_020105.xml · nonDerivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,291 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 02:03 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionOrdinary Shares | 17,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745347-26-000002 · form4-01092026_020105.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 07, 2026 Filed Apr 29, 2026 01:04 UTC Amendment | MeiraGTx Holdings plc MGTX · Entity 4734 | Tax withholdingOrdinary Shares | 7,814 | $7.73 | $60,402.22 |
DisclosureSEC source: 0001745347-26-000008 · form4a-04292026_010445.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,204 F1 · shares: Shares withheld for payment of taxes upon vesting of award. F2 · shares: Due to an administrative error, this Form 4 is being amended to reflect the correct number of shares withheld for payment of taxes upon vesting of award as well as the number of securities beneficially owned following the reported transaction. F2 · balance_after: Due to an administrative error, this Form 4 is being amended to reflect the correct number of shares withheld for payment of taxes upon vesting of award as well as the number of securities beneficially owned following the reported transaction. F3 · balance_after: Amount of securities beneficially owned has also been adjusted down by two shares due to rounding errors on two prior reports. Read SEC document |
| April 03, 2025 Filed Apr 8, 2025 01:04 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantRestricted Share Units · Derivative | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-010321 · form4-04082025_010438.xml · derivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Ordinary Shares · 90,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F2 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F2 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:37 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionRestricted Share Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-005616 · form4-02262025_010221.xml · derivative · entry 3 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-half of restricted share units granted on February 21, 2023. F1 · derivative.expiration_date: Represents vesting of one-half of restricted share units granted on February 21, 2023. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:37 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Tax withholdingOrdinary Shares | 5,903 | $7.30 | $43,091.90 |
DisclosureSEC source: 0001415889-25-005616 · form4-02262025_010221.xml · nonDerivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,520 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:37 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionOrdinary Shares | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-005616 · form4-02262025_010221.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-half of restricted share units granted on February 21, 2023. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:14 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionRestricted Share Units · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001580 · form4-01162025_110111.xml · derivative · entry 3 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 37,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:14 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Tax withholdingOrdinary Shares | 15,149 | $5.77 | $87,409.73 |
DisclosureSEC source: 0001415889-25-001580 · form4-01162025_110111.xml · nonDerivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,423 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 23:14 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionOrdinary Shares | 37,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001580 · form4-01162025_110111.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:08 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionRestricted Share Units · Derivative | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001339 · form4-01112025_020148.xml · derivative · entry 3 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:08 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Tax withholdingOrdinary Shares | 6,886 | $6.34 | $43,657.24 |
DisclosureSEC source: 0001415889-25-001339 · form4-01112025_020148.xml · nonDerivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,072 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 02:08 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionOrdinary Shares | 17,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001339 · form4-01112025_020148.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 7, 2022. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 17, 2024 Filed Jan 18, 2024 00:15 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantRestricted Share Units · Derivative | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001432 · form4-01182024_120128.xml · derivative · entry 5 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Ordinary Shares · 70,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F5 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F5 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| January 17, 2024 Filed Jan 18, 2024 00:15 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $6.16 | $0.00 |
DisclosureSEC source: 0001415889-24-001432 · form4-01182024_120128.xml · derivative · entry 4 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires 2034-01-17 F4 · derivative.exercise_date: The option vests as to one quarter of the total grant on January 17, 2025 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:15 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionRestricted Share Units · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001432 · form4-01182024_120128.xml · derivative · entry 3 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Ordinary Shares · 37,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:15 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Tax withholdingOrdinary Shares | 14,756 | $6.36 | $93,848.16 |
DisclosureSEC source: 0001415889-24-001432 · form4-01182024_120128.xml · nonDerivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,724 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 14, 2024 Filed Jan 18, 2024 00:15 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionOrdinary Shares | 37,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-001432 · form4-01182024_120128.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted share units granted on January 14, 2021. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 07, 2024 Filed Jan 9, 2024 22:27 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionRestricted Share Units · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000867 · form4-01092024_100116.xml · derivative · entry 3 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Ordinary Shares · 35,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-half of restricted share units granted on January 7, 2022. F1 · derivative.expiration_date: Represents vesting of one-half of restricted share units granted on January 7, 2022. Read SEC document |
| January 07, 2024 Filed Jan 9, 2024 22:27 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Tax withholdingOrdinary Shares | 18,507 | $6.30 | $116,594.10 |
DisclosureSEC source: 0001415889-24-000867 · form4-01092024_100116.xml · nonDerivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,980 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 07, 2024 Filed Jan 9, 2024 22:27 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionOrdinary Shares | 35,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-000867 · form4-01092024_100116.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-half of restricted share units granted on January 7, 2022. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| January 07, 2024 Filed Jan 18, 2024 22:17 UTC Amendment | MeiraGTx Holdings plc MGTX · Entity 4734 | Tax withholdingOrdinary Shares | 13,773 | $6.30 | $86,769.90 |
DisclosureSEC source: 0001415889-24-001527 · form4a-01182024_100113.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,714 F1 · shares: Shares withheld for payment of taxes upon vesting of award. F2 · shares: Due to an administrative error, this Form 4 is being amended to reflect the correct number of shares being withheld for payment of taxes as well as the number of securities beneficially owned following the reported transaction. F2 · balance_after: Due to an administrative error, this Form 4 is being amended to reflect the correct number of shares being withheld for payment of taxes as well as the number of securities beneficially owned following the reported transaction. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:59 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantRestricted Share Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-003199 · form4-02232023_090215.xml · derivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F3 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F3 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:59 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $8.60 | $0.00 |
DisclosureSEC source: 0001415889-23-003199 · form4-02232023_090215.xml · derivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires 2033-02-21 F1 · derivative.exercise_date: The option vests as to one quarter of the total grant on February 21, 2024 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| January 14, 2023 Filed Jan 18, 2023 22:05 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionRestricted Share Units · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-001091 · form4-01182023_100114.xml · derivative · entry 3 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Ordinary Shares · 75,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F1 · derivative.exercise_date: Represents vesting of one-half of restricted share units granted on January 14, 2021. F1 · derivative.expiration_date: Represents vesting of one-half of restricted share units granted on January 14, 2021. Read SEC document |
| January 14, 2023 Filed Jan 18, 2023 22:05 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Tax withholdingOrdinary Shares | 29,513 | $6.99 | $206,295.87 |
DisclosureSEC source: 0001415889-23-001091 · form4-01182023_100114.xml · nonDerivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,487 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| January 14, 2023 Filed Jan 18, 2023 22:05 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | Exercise / conversionOrdinary Shares | 75,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-001091 · form4-01182023_100114.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-half of restricted share units granted on January 14, 2021. F2 · price: Each restricted share unit converts into one ordinary share upon vesting. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 11:46 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | PurchaseOrdinary Shares | 6 | $7.89 | $47.34 |
DisclosureSEC source: 0001415889-22-006135 · form4-06062022_040613.xml · nonDerivative · entry 2 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 11:46 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | PurchaseOrdinary Shares | 4,994 | $7.90 | $39,452.60 |
DisclosureSEC source: 0001415889-22-006135 · form4-06062022_040613.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,994 Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 22:23 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantRestricted Share Units · Derivative | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000408 · edgar.xml · derivative · entry 2 Zeldin Robert K · CIK 0001745347 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Ordinary Shares · 70,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F3 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F3 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 22:23 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $21.53 | $0.00 |
DisclosureSEC source: 0001179110-22-000408 · edgar.xml · derivative · entry 1 Zeldin Robert K · CIK 0001745347 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires 2032-01-06 F1 · derivative.exercise_date: The option vests as to one quarter of the total grant on January 7, 2023 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 22:12 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantRestricted Share Units · Derivative | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000700 · edgar.xml · derivative · entry 2 Zeldin Robert K · CIK 0001745347 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Ordinary Shares · 150,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon vesting. F3 · derivative.exercise_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. F3 · derivative.expiration_date: Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 22:12 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $16.43 | $0.00 |
DisclosureSEC source: 0001179110-21-000700 · edgar.xml · derivative · entry 1 Zeldin Robert K · CIK 0001745347 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Ordinary Shares · 40,000 shares Expires 2031-01-13 F1 · derivative.exercise_date: The option vests as to one quarter of the total grant on January 14, 2022 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:41 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $13.24 | $0.00 |
DisclosureSEC source: 0000899243-20-021492 · doc4.xml · derivative · entry 1 Zeldin Robert K · CIK 0001745347 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Ordinary Shares · 150,000 shares Expires 2030-08-02 F1 · derivative.exercise_date: The option vests as to one quarter of the total grant on August 3, 2021 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 22:03 UTC | Immunovant, Inc. IMVT · Entity 3632 | GrantStock Option (right to buy) · Derivative | 380,325 | Not disclosed Strike: $7.86 | Not disclosed |
DisclosureSEC source: 0001209191-19-061604 · doc4.xml · derivative · entry 1 Zeldin Robert K · CIK 0001745347 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,325 Underlying: Common Stock · 380,325 shares Expires 2029-07-28 F2 · price: In connection with the share exchange transaction pursuant to which Health Sciences Acquisitions Corporation ("HSAC") acquired 100% of the issued and outstanding shares of Immunovant Sciences Ltd., the option to purchase 777,656 shares of Immunovant Sciences Ltd. at exercise price of $3.84 per share, was assumed by HSAC and converted into an option to purchase shares of the Issuer (formerly known as HSAC). F1 · derivative.exercise_date: 25% of the shares underlying the option vests on the first anniversary of the grant date, and the remainder vests in 12 equal quarterly installments thereafter. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 17:40 UTC | ACCELERON PHARMA INC XLRN · Entity 15780 | GrantOption to Purchase Common Stock · Derivative | 13,000 | $0.00 Strike: $41.64 | $0.00 |
DisclosureSEC source: 0001179110-19-001054 · edgar.xml · derivative · entry 2 Zeldin Robert K · CIK 0001745347 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2029-01-25 F1 · derivative.exercise_date: The shares of common stock underlying this stock option award vest in equal quarterly installments over the four years after January 1, 2019. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 17:40 UTC | ACCELERON PHARMA INC XLRN · Entity 15780 | GrantCommon Stock | 2,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001054 · edgar.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,103 Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 16:47 UTC | ACCELERON PHARMA INC XLRN · Entity 15780 | GrantOption to Purchase Common Stock · Derivative | 85,511 | $0.00 Strike: $47.33 | $0.00 |
DisclosureSEC source: 0001179110-18-009494 · edgar.xml · derivative · entry 2 Zeldin Robert K · CIK 0001745347 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,511 Underlying: Common Stock · 85,511 shares Expires 2028-07-02 F1 · derivative.exercise_date: The shares of common stock underlying this stock option award vest as to 25% of the shares on the first anniversary of June 29, 2018 and the remaining shares vest in equal quarterly installments over the following three years thereafter. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 16:47 UTC | ACCELERON PHARMA INC XLRN · Entity 15780 | GrantCommon Stock | 16,903 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009494 · edgar.xml · nonDerivative · entry 1 Zeldin Robert K · CIK 0001745347 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,903 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.